Drug intelligence based on MDMA tablets data. I. Organic impurities profiling

Forensic Science International

Volumn 177, Issue 1, 2008, Pages 11-16

  Weyermann, Céline ^a   Marquis, Raymond ^a   Delaporte, Céline ^a   Esseiva, Pierre ^a   Lock, Eric ^c   Aalberg, Laura ^d   Bozenko, Joseph S ^g   Dieckmann, Susanne ^e   Dujourdy, Laurence ^b   Zrcek, Frantisek ^f  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b Centre Universitaire des Saints Pères   (France)

^c NETHERLANDS FORENSIC INSTITUTE   (Netherlands)

^d National Bureau of Investigation Finland   (Finland)

^e Bundeskriminalamt   (Germany)

^f Policejni akademie Ceske republicky v Praze   (Czech Republic)

^g Drug Enforcement Administration   (United States)

Author keywords

Drug profiling; Ecstasy; GC MS; MDMA; Organic impurities; Statistics

Indexed keywords

3 (3,4 METHYLENEDIOXYPHENYL) 3 BUTEN 2 ONE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 3,4 METHYLENEDIOXYPHENYL 2 PROPANONE; 3,4 METHYLENEDIOXYPHENYL 2 PROPANONOL; DI [ (3,4 METHYLENEDIOXYPHENYL) 2 PROPYL]METHYLAMINE; DI [1 (3,4 METHYLENEDIOXYPHENYL) 2 PROPYL]AMINE; N ACETYL N METHYL 3,4 METHYLENEDIOXYAMPHETAMINE; N FORMYL N METHYL 3,4 METHYLENEDIOXYAMPHETAMINE; N [(3,4 METHYLENEDIOXYPHENYLMETHYL) N [2 (3,4 METHYLENEDIOXYPHENYL)]METHYLETHYL] N METHYLAMINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG IMPURITY; DRUG TRAFFIC; GAS CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; PRIORITY JOURNAL; TABLET COMPRESSION;

EID: 41049085796     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2007.10.001     Document Type: Article

References (11)

1. European Union, EU Drugs Action Plan (2005-2008), Official Journal (2005), C168, 01, Last access January 2007: http://europa.eu/scadplus/leg/en/cha/c22568.htm.
2. United Nations, World Drug Report: Analysis, Office on Drugs and Crime (2006), Last access January 2007: http://www.unodc.org/unodc/world_drug_report.html.
3. United Nations Office on Drugs and Crime, Drug Characterization/Impurity Profiling-Background and Concepts, Manual for use by national law enforcement authorities and drug testing laboratories, New York, 2001, Last access January 2007: http://www.unodc.org/pdf/publications/st-nar-32-rev1.pdf.
4. Esseiva P., Ioset S., Anglada F., Gaste L., Ribaux O., Margot P., Gallusser A., Biedermann A., Specht Y., and Ottinger E. Forensic drug intelligence: an important tool in law enforcement. Foren. Sci. Int. 167 2-3 (2007) 242-246
5. Voper C., van den Broom Wiarda W., Schrader M., de Joode P., van der Peijl G., and Bolck A. Elemental analysis of 3,4-methylenedioxymethamphetamine (MDMA): a tool to determine the synthesis method and trace links. Foren. Sci. Int. 171 2-3 (2007) 171-179
6. C. Zingg, The analysis of ecstasy tablets in a forensic drug intelligence perspective, Ph.D. Thesis, Institut de Police Scientifique, Lausanne University, Lausanne, 2005.
7. Van Deursen M.M., Lock E.R.A., and Poortman-van der Meer A.J. Organic profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets seized in The Netherlands. Sci. Justice 46 3 (2006) 135-152
8. E. Lock, Development of a harmonised method for the profiling of amphetamine, Ph.D. Thesis, Institut de Police Scientifique, University of Lausanne, Switzerland, 2005.
9. Esseiva P., Dujourdy L., Anglada F., Taroni F., and Margot P. A methodology for illicit heroin seizures comparison in a drug intelligence perspective using large databases. Foren. Sci. Int. 132 (2003) 139-152
10. Fawcett T. An introduction to ROC analysis. Pattern Recogn. Lett. 27 (2006) 861-874
11. Shah V., Midha K.K., Dighe S., McGilveray I.J., Skelly J.P., Yacobi A., Layloff T., Viswanathan C.T., Cook C.E., MCDowall R.D., Pittman K.A., and Spector S. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Pharm. Res. 9 (1992) 588-592